Shiftwork and prostate-specific antigen in the national health and nutrition examination survey

Journal of the National Cancer Institute

Volumn 105, Issue 17, 2013, Pages 1292-1297

  Flynn Evans, Erin E ^a   Mucci, Lorelei ^b   Stevens, Richard G ^b   Lockley, Steven W ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CIRCADIAN RHYTHM; DEMOGRAPHY; DISEASE ASSOCIATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; SHIFT WORKER; SLEEP TIME; WORK SCHEDULE;

ADULT; AGED; CIRCADIAN RHYTHM; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; ODDS RATIO; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; WORK SCHEDULE TOLERANCE;

EID: 84884472867     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt169     Document Type: Article

References (30)

1. Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. Does clock matter in prostate cancer? Cancer Epidemiol Biomarkers Prev. 2006;15(1):3-5.
2. Czeisler CA, Gooley JJ. Sleep and circadian rhythms in humans. Cold Spring Harb Symp Quant Biol. 2007;72:579-597.
3. Jung-Hynes B, Schmit TL, Reagan-Shaw SR, Siddiqui IA, Mukhtar H, Ahmad N. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res. 2011;50(2):140-149.
4. Pukkala E, Auvinen A, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants, 1967-92. BMJ. 1995;311(7006):649-652.
5. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001;93(20):1563-1568.
6. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005;97(14):1084-1087.
7. Pukkala E, Aspholm R, Auvinen A, et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ. 2002;325(7364):567.
8. Pukkala E, Martinsen JI, Lynge E, et al. Occupation and cancer-follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48(5):646-790.
9. Band PR, Le ND, Fang R, et al. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol. 1996;143(2):137-143.
10. Conlon M, Lightfoot N, Kreiger N. Rotating shiftwork and risk of prostate cancer. Epidemiology. 2007;18(1):182-183.
11. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate cancer among rotating-shiftworkers: findings from the Japan collaborative cohort study. Am J Epidemiol. 2006;164(6):549-555.
12. Kubo T, Oyama I, Nakamura T, et al. Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shiftworkers. Int J Urol. 2011;18(3):206-211.
13. Kakizaki M, Inoue K, Kuriyama S, et al. Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer. 2008;99(1):176-178.
14. Parent ME, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J. Night work and the risk of cancer among men. Am J Epidemiol. 2012;176(9):751-759.
15. Orsted DD, Nordestgaard BG, Jensen GB, Schnohr P, Bojesen SE. Prostatespecific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. Eur Urol. 2012;61(5):865-874.
16. Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA. 1998;279(19):1542-1547.
17. Welch HG, Schwartz LM, Woloshin S. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. J Natl Cancer Inst. 2005;97(15):1132-1137.
18. Orsted DD, Nordestgaard BG, Jensen GB, Schnohr P, Bojesen SE. Prostatespecific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. Eur Urol. 2012;61(5):865-874.
19. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007;8(12):1065-1066.
20. Luckhaupt SE, Tak S, Calvert GM. The prevalence of short sleep duration by industry and occupation in the National Health Interview Survey. Sleep. 2010;33(2):149-159.
21. Stevens RG, Blask DE, Brainard GC, et al. Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect. 2007;115(9):1357-1362.
22. Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW. Electric power, pineal function, and the risk of breast cancer. FASEB J. 1992;6(3):853-860.
23. Brainard GC, Hanifin JP. Photons, clocks, and consciousness. J Biol Rhythms. 2005;20(4):314-325.
24. Dijk DJ, Czeisler CA. Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neurosci Lett. 1994;166(1):63-68.
25. Morgan L, Hampton S, Gibbs M, Arendt J. Circadian aspects of postprandial metabolism. Chronobiol Int. 2003;20(5):795-808.
26. Richards J, Gumz ML. Advances in understanding the peripheral circadian clocks. FASEB J. 2012;26(9):3602-3613.
27. Arendt J. Melatonin: characteristics, concerns, and prospects. J Biol Rhythms. 2005;20(4):291-303.
28. Crowley SJ, Lee C, Tseng CY, Fogg LF, Eastman CI. Combinations of bright light, scheduled dark, sunglasses, and melatonin to facilitate circadian entrainment to night shiftwork. J Biol Rhythms. 2003;18(6):513-523.
29. Dumont M, Lanctot V, Cadieux-Viau R, Paquet J. Melatonin production and light exposure of rotating night workers. Chronobiol Int .2012;29(2):203-210.
30. Lin K, Lipsitz R, Miller T, Janakiraman S. Benefits and harms of prostatespecific antigen screening for prostate cancer: an evidence update for the US Preventive Services Task Force. Ann Intern Med. 2008;149(3):192-199.